Komori
Financial results presentation5129FIXER Inc.Information and Communications, Services and Others

Financial Results Briefing Materials for the Second Quarter of the Fiscal Year Ending August 2026

In the second quarter, revenue declined from the previous quarter, while the operating loss narrowed by ¥46 million, mainly due to fixed-cost controls. The Company also began accepting firm orders for Sovereign GaiXer and moved into the commercialisation phase aimed at restoring earnings in the second half.

Worth reading
65In focus
Scored from 5 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
46
¥ million
Wording
Conditional
How definitive the wording is.

Contents of this document

Financial results presentationSecond quarter of the fiscal year ending August 20268 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥773 million
Operating profit¥-613 million
Ordinary income¥-608 million
Net income¥-599 million net income attributable to owners of the parent
Selling, general and administrative expenses¥611 million
Gross Profit Margin
Rate-0.3%
Compared with the previous period-4.1pt
Operating profit margin
Rate-79.3%
Compared with the previous period+4.2pt
Results for the three months of the current quarter
Net Sales¥773 million
Cost of sales¥775 million
Gross profit−¥2 million
Operating profit–¥613 million
Ordinary income–¥608 million
Profit attributable to owners of the parent–¥599 million
Full-year earnings forecast
Net Sales¥4,348 million
Gross profit¥1,038 million
Operating profit–¥1,546 million
Ordinary income–¥1,541 million
Profit attributable to owners of the parent–¥1,566 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Personnel ExpensesDeclined from ¥590 million to ¥545 million, down ¥45 million from the first quarter
Advertising expensesDeclined from ¥31 million to ¥11 million, down ¥20 million from the first quarter
Outsourcing expensesIncreased from ¥17 million to ¥31 million, up ¥14 million from the first quarter
Selling, general and administrative expensesDown ¥78 million from the first quarter
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Sovereign GaiXer units sold394 units
Number of active distributors30 companies
AI Medical Affairs Manager ordersApproximately 80 cases
Sovereign GaiXer revenue¥951 million (¥100 million in the third quarter and ¥851 million in the fourth quarter)
New initiatives
  • Begin accepting firm orders for Sovereign GaiXer
  • Sell on-premises generative AI through a distributor-led channel
  • Release AI Medical Affairs Manager and expand deployments at medical institutions
  • Add voice input and automatic generation of discharge guidance documents to GaiXer Medical Agent
  • Develop GaiXer Review Agent, an AI content review system for broadcasters
Key KPIsA metric the company considers important as a management benchmark.
  • Cumulative number of GaiXer contractsMore than 200 companies
  • Sovereign GaiXer units sold (full-year outlook)394 Units
  • Number of active distributors (full-year plan)30 companies
  • AI Medical Affairs Manager leads30 Engagements
  • Expected orders for AI Medical Affairs Manager this fiscal year80 Engagements
  • GaiXer Medical Agent deployments10 Hospitals
Unit price and quantity metricsThese figures show sales broken down by price and volume.
Sovereign GaiXer
Selling Prices¥2.6 million per unit (excluding tax)
Unit sales394 units (full-year plan)
Segment results
Project-Based Services¥161 million (+¥13 million from the first quarter)
Resale¥390 million
Managed services¥143 million
SaaS¥53 million
Sovereign AI¥0 million
JV (Medical AI Solutions)¥24 million
Financial targets
Equity ratio: 78.4% (actual). Target: Not disclosed
Number of employees
Number of Employees330 employees (as of the end of the second quarter of the fiscal year ending August 2026)
Hiring plan15 new graduates to be hired in fiscal 2026
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredSecond quarter of the fiscal year ending August 2026
Net Sales¥773 million
Operating profit¥-613 million
Ordinary income¥-608 million
Net income¥-599 million (net income attributable to owners of the parent)
Gross Profit MarginRate -0.3% / Year on year against the same period last year Not disclosed / Compared with the previous period -4.1pt
Operating profit marginRate -79.3% / Year on year against the same period last year Not disclosed / Compared with the previous period +4.2pt
Selling, general and administrative expenses¥611 million
Results for the three months of the current quarterNet Sales ¥773 million / Cost of sales ¥775 million / Gross profit −¥2 million / Operating profit –¥613 million / Ordinary income –¥608 million / Profit attributable to owners of the parent –¥599 million
Full-year earnings forecastNet Sales ¥4,348 million / Gross profit ¥1,038 million / Operating profit –¥1,546 million / Ordinary income –¥1,541 million / Profit attributable to owners of the parent –¥1,566 million
Segment resultsProject-Based Services ¥161 million (+¥13 million from the first quarter) / Resale ¥390 million / Managed services ¥143 million / SaaS ¥53 million / Sovereign AI ¥0 million / JV (Medical AI Solutions) ¥24 million
Breakdown of Factors Affecting the ChangePersonnel Expenses Declined from ¥590 million to ¥545 million, down ¥45 million from the first quarter / Advertising expenses Declined from ¥31 million to ¥11 million, down ¥20 million from the first quarter / Outsourcing expenses Increased from ¥17 million to ¥31 million, up ¥14 million from the first quarter / Selling, general and administrative expenses Down ¥78 million from the first quarter
Key KPIsIndicator name Cumulative number of GaiXer contracts / Value More than 200 companies / Year on year against the same period last year Not disclosed, Indicator name Sovereign GaiXer units sold (full-year outlook) / Value 394 Units / Year on year against the same period last year Not disclosed, Indicator name Number of active distributors (full-year plan) / Value 30 companies / Year on year against the same period last year Not disclosed, Indicator name AI Medical Affairs Manager leads / Value 30 Engagements / Year on year against the same period last year Not disclosed, Indicator name Expected orders for AI Medical Affairs Manager this fiscal year / Value 80 Engagements / Year on year against the same period last year Not disclosed, Indicator name GaiXer Medical Agent deployments / Value 10 Hospitals / Year on year against the same period last year Not disclosed
Unit price and quantity metricsSovereign GaiXer Selling Prices ¥2.6 million per unit (excluding tax) / Unit sales 394 units (full-year plan)
Number of employeesNumber of Employees 330 employees (as of the end of the second quarter of the fiscal year ending August 2026) / Change during the period Not disclosed / Hiring plan 15 new graduates to be hired in fiscal 2026
Assumptions Underlying the Business OutlookSovereign GaiXer units sold 394 units / Number of active distributors 30 companies / AI Medical Affairs Manager orders Approximately 80 cases / Sovereign GaiXer revenue ¥951 million (¥100 million in the third quarter and ¥851 million in the fourth quarter)
Financial targetsEquity ratio: 78.4% (actual). Target: Not disclosed
New initiativesBegin accepting firm orders for Sovereign GaiXer, Sell on-premises generative AI through a distributor-led channel, Release AI Medical Affairs Manager and expand deployments at medical institutions, Add voice input and automatic generation of discharge guidance documents to GaiXer Medical Agent, Develop GaiXer Review Agent, an AI content review system for broadcasters
Items this document does not state (12)
Progress against full-year forecastSelf-assessment against the planNumber of stores and locationsRisk amount incorporated into the outlookMedium-term management plan targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The loss narrowed due to the recovery of existing businesses, fixed-cost controls, and reductions in personnel expenses and advertising expenses. For Sovereign GaiXer, the Company is targeting an earnings recovery through the completion of initial development, commercialisation, and the full-scale recognition of revenue in the fourth quarter.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Briefing Materials for the Second Quarter of the Fiscal Year Ending August 2026 | FIXER Inc. (5129) timely disclosure | Komori